RU2013145233A - MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX - Google Patents
MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX Download PDFInfo
- Publication number
- RU2013145233A RU2013145233A RU2013145233/15A RU2013145233A RU2013145233A RU 2013145233 A RU2013145233 A RU 2013145233A RU 2013145233/15 A RU2013145233/15 A RU 2013145233/15A RU 2013145233 A RU2013145233 A RU 2013145233A RU 2013145233 A RU2013145233 A RU 2013145233A
- Authority
- RU
- Russia
- Prior art keywords
- nanoparticles
- porphyrin complex
- diagnosis
- diagnostic
- magnetometric
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Магнитометрический способ диагностики онкологических заболеваний с помощью наночастиц Yb-порфиринового комплекса, основанный на введении наночастиц указанного комплекса в исследуемую ткань и регистрации сигнала от злокачественных тканей, отличающийся тем, что, с целью повышения точности диагностики и уменьшения дозы вводимого контрастного вещества, регистрируют магнитный отклик, обусловленный магнетизмом иона Yb, селективно накопленного в ткани в результате ее малигнизации.A magnetometric method for the diagnosis of cancer using nanoparticles of the Yb-porphyrin complex, based on the introduction of nanoparticles of the specified complex into the test tissue and registration of a signal from malignant tissues, characterized in that, in order to increase the accuracy of diagnosis and reduce the dose of the injected contrast agent, the magnetic response is recorded, due to the magnetism of the Yb ion, selectively accumulated in the tissue as a result of its malignancy.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013145233/15A RU2013145233A (en) | 2013-10-09 | 2013-10-09 | MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013145233/15A RU2013145233A (en) | 2013-10-09 | 2013-10-09 | MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2013145233A true RU2013145233A (en) | 2015-04-20 |
Family
ID=53282650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013145233/15A RU2013145233A (en) | 2013-10-09 | 2013-10-09 | MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2013145233A (en) |
-
2013
- 2013-10-09 RU RU2013145233/15A patent/RU2013145233A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502205A1 (en) | New gadolinium chelate compounds for use in magnetic resonance imaging | |
MX2021008976A (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer. | |
BR112016002000A2 (en) | CANCER DIAGNOSIS AND THERAPY INVOLVING TUMOR STEM CELLS | |
EA201690549A1 (en) | ARILETHER AND THEIR APPLICATION | |
MX2018007043A (en) | Dimeric contrast agents. | |
BR112012020304A2 (en) | tissue targeting complex, use of a tissue targeting complex, method of treating a human or non-human animal body, pharmaceutical composition, and kit | |
PH12015500252A1 (en) | Niclosamide for the treatment of solid tumors | |
SA518391121B1 (en) | 18f-tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer | |
MX362675B (en) | Grpr-antagonists for detection, diagnosis and treatment of grpr-positive cancer. | |
NZ710436A (en) | Biospecific agents for bone | |
EP3060260A4 (en) | Methods and diagnostic kit for visualizing body tissues and components therein | |
ES2540255A1 (en) | Method of isolation of apoptotic bodies (Machine-translation by Google Translate, not legally binding) | |
WO2015081283A3 (en) | Long non-coding rna as a diagnostic and therapeutic agent | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
UY37500A (en) | NEW GADOLIN CHELATE COMPOUNDS WITH HIGH RELAXIVITY TO USE IN THE OBTAINING OF IMAGES BY MAGNETIC RESONANCE | |
MX2018016082A (en) | Chelate compounds. | |
CO6592030A2 (en) | Use of ventricular dilation rate in the treatment of Alzheimer's disease with intravenous immunoglobulin | |
MX2016006584A (en) | Methods and compositions for treating amyloid deposits. | |
RU2013145233A (en) | MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX | |
WO2015023694A3 (en) | Method for enhancing tumor growth | |
WO2014143794A3 (en) | Diagnostic and prognostic marker for prostate cancer | |
Epstein | Re: Editorial comment on urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection (Health Aff [Millwood] 2012; 31: 741-749): PC Walsh J Urol 2012; 188: 1767 | |
Decelle et al. | Evaluation of prostate cancer metabolomic field effects using prostate needle biopsies | |
RU2013156065A (en) | METHOD FOR PRODUCING MATERIAL FOR DIAGNOSTIC OF GLIAL BRAIN NORMAL FORMATIONS | |
UA75720U (en) | method for liver biopsy in farming sheep |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20150629 |